| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Kim Donoghue, Gillian A Doody, Robin M Murray, Peter B Jones, Craig Morgan, Paola Dazzan, Jozella Hart, Rodolfo Mazzoncini, James H Maccab. Cannabis use, gender and age of onset of schizophrenia: data from the ÆSOP study. Psychiatry research. vol 215. issue 3. 2015-03-18. PMID:24461684. |
cannabis use, gender and age of onset of schizophrenia: data from the Æsop study. |
2015-03-18 |
2023-08-12 |
Not clear |
| Kim Donoghue, Gillian A Doody, Robin M Murray, Peter B Jones, Craig Morgan, Paola Dazzan, Jozella Hart, Rodolfo Mazzoncini, James H Maccab. Cannabis use, gender and age of onset of schizophrenia: data from the ÆSOP study. Psychiatry research. vol 215. issue 3. 2015-03-18. PMID:24461684. |
the current study examines the interaction effect of gender and cannabis use on age of onset of schizophrenia and schizoaffective disorder. |
2015-03-18 |
2023-08-12 |
Not clear |
| Kim Donoghue, Gillian A Doody, Robin M Murray, Peter B Jones, Craig Morgan, Paola Dazzan, Jozella Hart, Rodolfo Mazzoncini, James H Maccab. Cannabis use, gender and age of onset of schizophrenia: data from the ÆSOP study. Psychiatry research. vol 215. issue 3. 2015-03-18. PMID:24461684. |
kaplan-meier curves and cox proportional hazards regression were used to compare the effects of cannabis use and gender on age of first symptom of schizophrenia. |
2015-03-18 |
2023-08-12 |
Not clear |
| Andrei Szoke, Anne-Marie Galliot, Jean-Romain Richard, Aziz Ferchiou, Grégoire Baudin, Marion Leboyer, Franck Schürhof. Association between cannabis use and schizotypal dimensions--a meta-analysis of cross-sectional studies. Psychiatry research. vol 219. issue 1. 2015-03-18. PMID:24878296. |
several literature reviews explored the link between cannabis consumption and schizophrenia but none summarized the rich literature on cannabis and psychometric schizotypy. |
2015-03-18 |
2023-08-13 |
human |
| Katherine A Epstein, Sanjiv Kumr. Executive attention impairment in adolescents with schizophrenia who have used cannabis. Schizophrenia research. vol 157. issue 1-3. 2015-02-26. PMID:24875171. |
executive attention impairment in adolescents with schizophrenia who have used cannabis. |
2015-02-26 |
2023-08-13 |
Not clear |
| Katherine A Epstein, Sanjiv Kumr. Executive attention impairment in adolescents with schizophrenia who have used cannabis. Schizophrenia research. vol 157. issue 1-3. 2015-02-26. PMID:24875171. |
repeated exposure to cannabis in nonpsychotic adolescents is associated with impairments in executive control of attention, similar to those observed in young adults with first-episode schizophrenia. |
2015-02-26 |
2023-08-13 |
Not clear |
| Katherine A Epstein, Sanjiv Kumr. Executive attention impairment in adolescents with schizophrenia who have used cannabis. Schizophrenia research. vol 157. issue 1-3. 2015-02-26. PMID:24875171. |
to assess the impact of recurrent exposure to cannabis on cognitive function, this study characterized attention performance in both nonpsychotic adolescents and adolescents with early-onset schizophrenia (eos). |
2015-02-26 |
2023-08-13 |
Not clear |
| Carsten Rygaard Hjorthoj, Amanda Baker, Allan Fohlmann, Merete Nordentof. Intervention efficacy in trials targeting cannabis use disorders in patients with comorbid psychosis systematic review and meta-analysis. Current pharmaceutical design. vol 20. issue 13. 2015-02-20. PMID:23829367. |
cannabis use disorders are highly prevalent in patients with schizophrenia and other psychoses, and are probably associated with a range of poor outcomes. |
2015-02-20 |
2023-08-12 |
Not clear |
| Martin Cohen, Paul E Rasser, Greg Peck, Vaughan J Carr, Philip B Ward, Paul M Thompson, Patrick Johnston, Amanda Baker, Ulrich Schal. Cerebellar grey-matter deficits, cannabis use and first-episode schizophrenia in adolescents and young adults. The international journal of neuropsychopharmacology. vol 15. issue 3. 2015-01-22. PMID:21557880. |
cerebellar grey-matter deficits, cannabis use and first-episode schizophrenia in adolescents and young adults. |
2015-01-22 |
2023-08-12 |
human |
| Martin Cohen, Paul E Rasser, Greg Peck, Vaughan J Carr, Philip B Ward, Paul M Thompson, Patrick Johnston, Amanda Baker, Ulrich Schal. Cerebellar grey-matter deficits, cannabis use and first-episode schizophrenia in adolescents and young adults. The international journal of neuropsychopharmacology. vol 15. issue 3. 2015-01-22. PMID:21557880. |
epidemiological data link adolescent cannabis use to psychosis and schizophrenia, but its contribution to schizophrenia neuropathology remains controversial. |
2015-01-22 |
2023-08-12 |
human |
| Jacob Cookey, Denise Bernier, Philip G Tibb. White matter changes in early phase schizophrenia and cannabis use: an update and systematic review of diffusion tensor imaging studies. Schizophrenia research. vol 156. issue 2-3. 2015-01-20. PMID:24842540. |
white matter changes in early phase schizophrenia and cannabis use: an update and systematic review of diffusion tensor imaging studies. |
2015-01-20 |
2023-08-13 |
Not clear |
| Jacob Cookey, Denise Bernier, Philip G Tibb. White matter changes in early phase schizophrenia and cannabis use: an update and systematic review of diffusion tensor imaging studies. Schizophrenia research. vol 156. issue 2-3. 2015-01-20. PMID:24842540. |
the impact of cannabis use on the brain tissue is still unclear, both in the healthy developing brain and in people with schizophrenia. |
2015-01-20 |
2023-08-13 |
Not clear |
| Michael A P Bloomfield, Celia J A Morgan, Alice Egerton, Shitij Kapur, H Valerie Curran, Oliver D Howe. Dopaminergic function in cannabis users and its relationship to cannabis-induced psychotic symptoms. Biological psychiatry. vol 75. issue 6. 2015-01-19. PMID:23820822. |
cannabis is the most widely used illicit drug globally, and users are at increased risk of mental illnesses including psychotic disorders such as schizophrenia. |
2015-01-19 |
2023-08-12 |
Not clear |
| Michael A P Bloomfield, Celia J A Morgan, Alice Egerton, Shitij Kapur, H Valerie Curran, Oliver D Howe. Dopaminergic function in cannabis users and its relationship to cannabis-induced psychotic symptoms. Biological psychiatry. vol 75. issue 6. 2015-01-19. PMID:23820822. |
it has been proposed, although never directly tested, that the link between cannabis use and schizophrenia is mediated by altered dopaminergic function. |
2015-01-19 |
2023-08-12 |
Not clear |
| Lisa-Marie Greenwood, Samantha J Broyd, Rodney Croft, Juanita Todd, Patricia T Michie, Stuart Johnstone, Robin Murray, Nadia Solowi. Chronic effects of cannabis use on the auditory mismatch negativity. Biological psychiatry. vol 75. issue 6. 2015-01-19. PMID:23830666. |
cannabis use is associated with the development of psychotic symptoms and increased risk for schizophrenia. |
2015-01-19 |
2023-08-12 |
human |
| Denise Bernier, Jacob Cookey, David McAllindon, Robert Bartha, Christopher C Hanstock, Aaron J Newman, Sherry H Stewart, Philip G Tibb. Multimodal neuroimaging of frontal white matter microstructure in early phase schizophrenia: the impact of early adolescent cannabis use. BMC psychiatry. vol 13. 2015-01-06. PMID:24131511. |
multimodal neuroimaging of frontal white matter microstructure in early phase schizophrenia: the impact of early adolescent cannabis use. |
2015-01-06 |
2023-08-12 |
Not clear |
| Denise Bernier, Jacob Cookey, David McAllindon, Robert Bartha, Christopher C Hanstock, Aaron J Newman, Sherry H Stewart, Philip G Tibb. Multimodal neuroimaging of frontal white matter microstructure in early phase schizophrenia: the impact of early adolescent cannabis use. BMC psychiatry. vol 13. 2015-01-06. PMID:24131511. |
the aim of this in vivo neuroimaging project is to assess the impact of early adolescent onset of regular cannabis use on brain white matter tissue integrity, and to differentiate this impact from the white matter abnormalities associated with schizophrenia. |
2015-01-06 |
2023-08-12 |
Not clear |
| Benjamin C McLoughlin, Jonathan A Pushpa-Rajah, Donna Gillies, John Rathbone, Hannele Variend, Eliana Kalakouti, Katerina Kypriano. Cannabis and schizophrenia. The Cochrane database of systematic reviews. issue 10. 2014-12-19. PMID:25314586. |
cannabis and schizophrenia. |
2014-12-19 |
2023-08-13 |
Not clear |
| Benjamin C McLoughlin, Jonathan A Pushpa-Rajah, Donna Gillies, John Rathbone, Hannele Variend, Eliana Kalakouti, Katerina Kypriano. Cannabis and schizophrenia. The Cochrane database of systematic reviews. issue 10. 2014-12-19. PMID:25314586. |
many people with schizophrenia smoke cannabis, and it is unclear why a large proportion do so and if the effects are harmful or beneficial. |
2014-12-19 |
2023-08-13 |
Not clear |
| Benjamin C McLoughlin, Jonathan A Pushpa-Rajah, Donna Gillies, John Rathbone, Hannele Variend, Eliana Kalakouti, Katerina Kypriano. Cannabis and schizophrenia. The Cochrane database of systematic reviews. issue 10. 2014-12-19. PMID:25314586. |
it is also unclear what the best method is to allow people with schizophrenia to alter their cannabis intake. |
2014-12-19 |
2023-08-13 |
Not clear |